Folgen
Ben Forbes
Ben Forbes
Bestätigte E-Mail-Adresse bei kcl.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ...
The Lancet Psychiatry 3 (7), 619-627, 2016
14512016
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ...
Psychopharmacology 235, 399-408, 2018
8482018
Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier
CI Grainger, LL Greenwell, DJ Lockley, GP Martin, B Forbes
Pharmaceutical research 23, 1482-1490, 2006
4222006
Hyaluronan: pharmaceutical characterization and drug delivery
YH Liao, SA Jones, B Forbes, GP Martin, MB Brown
Drug delivery 12 (6), 327-342, 2005
4082005
Human respiratory epithelial cell culture for drug delivery applications
B Forbes, C Ehrhardt
European journal of pharmaceutics and biopharmaceutics 60 (2), 193-205, 2005
3712005
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro
A Grenha, CI Grainger, LA Dailey, B Seijo, GP Martin, C Remuñán-López, ...
European Journal of Pharmaceutical Sciences 31 (2), 73-84, 2007
2902007
Human airway epithelial cell lines for in vitro drug transport and metabolism studies
B Forbes
Pharmaceutical science & technology today 3 (1), 18-27, 2000
2132000
The human bronchial epithelial cell line 16HBE14o− as a model system of the airways for studying drug transport
B Forbes, A Shah, GP Martin, AB Lansley
International journal of pharmaceutics 257 (1-2), 161-167, 2003
1872003
In vitro models of inhalation toxicity and disease
K BeruBe, M Aufderheide, D Breheny, R Clothier, R Combes, R Duffin, ...
Alternatives to laboratory animals 37 (1), 89-141, 2009
1712009
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
FA Stressmann, GB Rogers, CJ Van Der Gast, P Marsh, LS Vermeer, ...
Thorax 67 (10), 867-873, 2012
1642012
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
FA Stressmann, GB Rogers, P Marsh, AK Lilley, TWV Daniels, MP Carroll, ...
Journal of Cystic Fibrosis 10 (5), 357-365, 2011
1582011
In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits
ST Lim, B Forbes, DJ Berry, GP Martin, MB Brown
International journal of pharmaceutics 231 (1), 73-82, 2002
1572002
Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles
AC Silva, A Kumar, W Wild, D Ferreira, D Santos, B Forbes
International journal of pharmaceutics 436 (1-2), 798-805, 2012
1392012
Challenges in inhaled product development and opportunities for open innovation
B Forbes, B Asgharian, LA Dailey, D Ferguson, P Gerde, M Gumbleton, ...
Advanced drug delivery reviews 63 (1-2), 69-87, 2011
1352011
Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis
M Tebruegge, B Dutta, S Donath, N Ritz, B Forbes, K Camacho-Badilla, ...
American journal of respiratory and critical care medicine 192 (4), 485-499, 2015
1342015
Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers
RH Khengar, SA Jones, RB Turner, B Forbes, MB Brown
Pharmaceutical research 24, 2207-2212, 2007
1222007
The relationships and susceptibilities of some industrial, laboratory and clinical isolates of Pseudomonas aeruginosa to some antibiotics and biocides
RJW Lambert, J Joynson, B Forbes
Journal of applied microbiology 91 (6), 972-984, 2001
1042001
The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa
CI Grainger, LL Greenwell, GP Martin, B Forbes
European Journal of Pharmaceutics and Biopharmaceutics 71 (2), 318-324, 2009
1032009
Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement
MB Brown, RH Khengar, RB Turner, B Forbes, MJ Traynor, CRG Evans, ...
International journal of pharmaceutics 370 (1-2), 61-67, 2009
1022009
Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs
P Bäckman, S Arora, W Couet, B Forbes, W de Kruijf, A Paudel
European Journal of Pharmaceutical Sciences 113, 41-52, 2018
952018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20